Journal of the Neurological Sciences
Volume 211, Issue 1 , Pages 49-53, 15 July 2003

The prevalence and clinical characteristics of MS in northern Japan

  • Hideki Houzen

      Affiliations

    • Department of Neurology, Obihiro Kosei General Hospital, Obihiro, Japan
    • These authors contributed equally to this work.
  • ,
  • Masaaki Niino

      Affiliations

    • Department of Neurology, Hokkaido University Graduate School of Medicine, Kita-15 Nishi-7, Kita-ku, Sapporo 060-8638, Japan
    • These authors contributed equally to this work.
  • ,
  • Seiji Kikuchi

      Affiliations

    • Corresponding Author InformationCorresponding author. Tel.: +81-11-706-6028; fax: +81-11-700-5356.
    • Department of Neurology, Hokkaido University Graduate School of Medicine, Kita-15 Nishi-7, Kita-ku, Sapporo 060-8638, Japan
  • ,
  • Toshiyuki Fukazawa

      Affiliations

    • Hokuyukai Neurology Hospital, Sapporo, Japan
  • ,
  • Shinji Nogoshi

      Affiliations

    • Department of Neurology, Obihiro Kosei General Hospital, Obihiro, Japan
  • ,
  • Hiroyuki Matsumoto

      Affiliations

    • Department of Neurology, Sapporo Medical University School of Medicine, Sapporo, Japan
  • ,
  • Kunio Tashiro

      Affiliations

    • Department of Neurology, Hokkaido University Graduate School of Medicine, Kita-15 Nishi-7, Kita-ku, Sapporo 060-8638, Japan

Received 14 November 2002; received in revised form 4 February 2003; accepted 5 February 2003.

Abstract 

In Japan, there is a low prevalence rate (PR) of multiple sclerosis (MS; 0.8–4.0/100,000) but a relatively high frequency of “optic-spinal form” MS (OS-MS). There have been no intensive epidemiologic frequency studies, however, in over 30 years. We performed a province-wide prevalence study of MS in the Tokachi province of Hokkaido, the northernmost island of Japan, and compared the observed clinical features with other populations in Japan and Western countries. Prevalence was determined on March 31, 2001. The primary sources for the case ascertainment were 13 hospitals that treated patients with neurologic diseases including MS in Tokachi. Patients were classified according to Poser's criteria. The prevalence rate of clinically definite or laboratory-supported definite MS (LSDMS) was 8.57 per 100,000 [31/361,726; male/female ratio=1:2.9, and age at onset=29.1±14.2 (mean±SD) years]. Out of the 31 patients, 5 (16%) were classified as OS-MS. The prevalence rate of MS in the Tokachi province was the highest reported in Orientals to date, although still low in comparison with Western communities at a similar latitude. In contrast to the previous reports in Japan, there was a relatively low frequency of OS-MS in Hokkaido.

Keywords:  Multiple sclerosis, Japanese, Prevalence rate, MRI, HLA, Optic neuritis

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

PII: S0022-510X(03)00033-9

doi:10.1016/S0022-510X(03)00033-9

Journal of the Neurological Sciences
Volume 211, Issue 1 , Pages 49-53, 15 July 2003